The b and a2d auxiliary subunits of voltage-gated calcium channel 1 (Ca v 1) are required for T H 
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The auxiliary subunits of Ca v 1 channels are required for Th2-lymphocyte function and acute allergic airway inflammation Allergic diseases, including rhinitis, atopic dermatitis, asthma, and food allergies, are induced by T H 2 lymphocytes. T H 2-type responses are characterized by production of IL-4, IL-5, and IL-13, which contribute to mucus production, eosinophilia, and high levels of antigen-specific IgE. At present, treatments for allergic asthma are often symptomatic, even if in some cases specific allergenic immunotherapy and treatments targeting the cytokines (or their receptors) involved in type 2 inflammation can be beneficial. 1, 2 The main immunosuppressants (eg, cyclosporine and tacrolimus) have also been proposed for use in patients with severe asthma resistant to glucocorticoids. However, because they decrease the activity of T cells and therefore the overall immune response by acting on calcium signaling, they have adverse effects.
Calcium is a second messenger that plays specific and key roles in various cellular functions, such as activation, differentiation, proliferation, and death. The role of store-operated Ca 21 entry is well described, implicating the sensing of T-cell receptor (TCR)-driven endoplasmic reticulum (ER) Ca 21 depletion by stromal interaction molecule 1, its oligomerization, and its localization in the vicinity of calcium release-activated calcium modulator 1 (ORAI1) channels at the plasma membrane, permitting sustained Ca 21 entry. 3 In addition to these channels, the role of voltage-gated calcium channel (Ca v ) 1 channels (defined as voltage activated in excitable cells) in T lymphocytes is now accepted. [4] [5] [6] [7] [8] [9] [10] [11] In excitable cells, Ca v 1 channels are composed of the ion-forming pore a1 and auxiliary b and a2d subunits, with each subunit being encoded by 4 genes. Ca v 1.1 to Ca v 1.4 a1 form the ion pore and support the biophysical and pharmacologic properties of the channel, [12] [13] [14] whereas auxiliary b and a2d subunits increase Ca v currents by enhancing the number of channels at the cell membrane and favoring channel opening. [15] [16] [17] [18] [19] Ca v b would act by facilitating the correct folding of a1 and promoting its exit from the ER, 20 whereas Ca v a2d increases insertion of the channel into the cell membrane by favoring the trafficking of the channel from the post-Golgi apparatus and decreasing its turnover. [21] [22] [23] While Ca v b2 deletion 24 inhibited thymocyte development, Ca v b3 and Ca v b4 were found to be important for calcium influx, nuclear factor of activated T cells (NFAT) nuclear translocation, and cytokine production by peripheral CD4 1 T lymphocytes. Previously, we reported that Ca v 1.2 was expressed and functional in human and mouse T H 2 cells. 7, 9, 25 In contrast, T H 1 and T H 17 lymphocytes in both species lacked Ca v 1.2 expression.
Here we address whether Ca v auxiliary subunits are required for channel functions in T H 2 lymphocytes. We show that Ca v b1, Ca v b3, and a2d2 subunits are expressed in mouse and human T H 2 cells. Knocking down Ca v b promoted degradation of Ca v 1.2 a1, which was at least partly rescued by adding MG132, a proteasome inhibitor, whereas gabapentin, an inhibitor of a2d1/2 subunits, decreased a2d2 protein levels in T H 2 lymphocytes. In both cases, it was associated with a decreased TCR-dependent intracellular Ca 21 concentration ([Ca 21 ] i ) increase and T H 2 cytokine production. In accordance with our in vitro results, targeting either Ca v b or a2d in vivo was beneficial in a model of acute allergic airway inflammation.
METHODS
More details are provided in the Methods section in this article's Online Repository at www.jacionline.org.
Mice and model of acute airway allergic inflammation
Eight-to 12-week-old female BALB/c mice were obtained from Janvier (Le Genest St Isle, France), and TCR ovalbumin (OVA) transgenic DO11.10 mice were maintained in our pathogen-free animal facility. The INSERM U1043 Institutional Review Board for animal experimentation approved protocols. BALB/c mice immunized intraperitoneally with OVA (100 mg) in alum (2 mg) were 15 days later administered intranasal OVA (50 mg/d) in PBS for 5 days, as previously described, 7 with or without Ca v b scrambled (Ca v bS) 
Single-cell calcium imaging
Single-cell calcium imaging was done, as previously described, 7, 9 in cells loaded with Fura-2 AM before and after stimulation with biotinylated anti-CD3 cross-linked with streptavidin or anti-CD3/CD28-coated beads (1 bead per cell) for mouse or human T cells, respectively.
Confocal microscopy
Cells were stained with anti-CD2 rat IgG antibody (Abcam, Cambridge, United Kingdom) or anti-a2d2 rabbit antibody (Alomone Labs, Jerusalem, Israel) fixed, permeabilized and the Ca v channel subunit staining was performed by using anti-Ca v 1.2 mouse IgG 2b (NeuroMab, Davis, Calif), anti-Ca v b1 (Alomone Labs), or anti-Ca v b3 rabbit IgG (Santa Cruz Labs, Santa Cruz, Calif).
Real-time quantitative PCR
RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription was performed with SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, Calif), and mRNA transcripts were measured by using real-time quantitative PCR with a LightCycler 480 Instrument (Roche, Mannheim, Germany). 
ELISA
For in vitro cytokine assays, 5 3 10 4 T H 1 and T H 2 cells were seeded onto plates coated with anti-CD3 antibodies (3 mg/mL) and stimulated with soluble anti-CD28 antibodies (1 mg/mL). Supernatants were collected 24 hours later. For in vivo IgE assays, sera were isolated from blood collected into the mouse retro-orbital sinus. Cytokine and immunoglobulin levels were quantified by using the sandwich ELISA method.
Statistical analysis
Groups were compared by using the paired or unpaired t test as needed with GraphPad Prism software (GraphPad Software, La Jolla, Calif).
RESULTS
Knocking down Ca v b subunits decreases cytokine production induced by TCR engagement in mouse and human T H 2 cells Murine T H 2 cells expressed principally Ca v b1 and Ca v b3 transcripts (Fig 1, A) , as did human T H 2 cells. 9 The proteins Ca v b1 and Ca v b3 were detected by Western blotting with the same apparent molecular weights as the control neuronal forms (Fig 1, B) and by immunofluorescence (see Fig E1, A and B, in this article's Online Repository at www.jacionline.org). Although T H 1 cells did not express Ca v a1 subunits, they did express Ca v b1 and Ca v b3 at both the transcriptional (Fig 1, A) and protein levels, with lower amounts compared with those in T H 2 cells (see Fig E1,  A and B) .
To investigate whether b subunits were important for T H 2 functions, we used antisense oligonucleotides targeting the 4 Ca v b subunits in mice and human subjects. 27 Transfection of mouse T H 2 cells with Ca v bAS decreased the amount of Ca v b1 and Ca v b3 subunits by Western blotting (see Fig E1, C and D) and by immunofluorescence (see Fig E1, E and F), with no effect on expression of ORAI1, a calcium channel important for T-cell function (see Fig E1, C and D) . Ca v bAS decreased IL-4, IL-5, and IL-13 production by 50% to 70% in mouse T H 2 cells compared with Ca v bS-transfected T H 2 cells (Fig 1, C) without any effect on IFN-g production by T H 1 cells (Fig 1, D) .
Human memory T H 2 cells were selected based on expression of the cell membrane marker CRTH2 and were expanded with anti-CD3/anti-CD28-coated beads in the presence of IL-4 and IL-2. Transfection of human T H 2 lymphocytes with Ca v bAS reduced the amount of Ca v b subunits at the mRNA level (see Fig E1, G) associated with significant diminution of T H 2 cytokine production (Fig 1, E) without any effect on IFN-g production by human T H 1 cells (Fig 1, F (Fig 2, A) . Indeed, Ca v bAS-transfected T H 2 cells presented a significantly reduced area under the curve compared with control T H 2 cells (Fig 2, B) . A significant number of Ca v bAS-transfected T H 2 cells (21% 6 5%) did not show any increase in [Ca 21 ] i levels after TCR stimulation, whereas most control T H 2 cells (98% 6 2%) did (P < .005). Moreover, among responsive cells, Ca v bAS-transfected T H 2 cells had a delayed calcium response compared with control cells (Fig 2, C) . However, ionomycin application at the end of the experiment induced a similar [Ca 21 ] i increase in T H 2 cells, irrespective of whether they were transfected with Ca v bS or Ca v bAS (Fig 2, A) , indicating that Ca v bAS did not affect loading with the Fura-2 probe.
Ca v bAS had the same effect on the TCR-driven [Ca 21 ] i increase of human T H 2 lymphocytes with a delayed and reduced [Ca 21 ] i increase (Fig 2, D-F) . Conversely, transfection of mouse (see Fig 2, G-I) or human (Fig 2, J-L) T H 1 cells with Ca v bAS had no effect on the shape and the amplitude of the calcium response induced by TCR stimulation, which is in agreement with the lack of an effect of Ca v bAS on IFN-g synthesis by T H 1 cells (Fig 1, D and F ).
An inhibitor of the proteasome protects the Ca v 1.2 a1 subunit from degradation in the absence of Ca v b but does not restore cytokine production One possible role of Ca v b subunits could be to prevent Ca v 1.2 degradation by the proteasome. 28 In agreement with this hypothesis, we showed that transfection of T H 2 cells with Ca v bAS did not affect levels of Ca v 1.2 a1 transcripts (Fig 3, A) but strongly reduced the amount of Ca v 1.2 a1 protein in mouse (Fig 3, B and C) and human (Fig 3, D and E) cells. The proteasome inhibitor MG132 had no effect on amounts of Ca v b1 (Fig 4, A) and Ca v b3 (Fig 4, B) proteins, but it partially restored Ca v 1.2 a1 protein expression in murine T H 2 cells (Fig 4, C) . Analysis of colocalization of Ca v 1.2 a1 with CD2 used as a cell membrane marker shows that Ca v bAS decreases the amount of protein localized at the cell membrane, which was partially restored by MG132 (see Fig E2 in this article's Online Repository at www.jacionline.org). However, MG132 treatment did not allow restoration of cytokine production by T H 2 cells transfected with Ca v bAS (Fig 4, D) , suggesting that the Ca v b subunit could also contribute to regulate channel function, as previously reported.
29-31
Intranasal delivery of Ca v bAS alleviates T H 2-dependent airway inflammation
With the goal to investigate the role of Ca v b in vivo, we evaluated whether Ca v bAS modified the course of allergic airway inflammation. Immunization with OVA in alum followed by inhalation of OVA (Fig 5, A) triggered T H 2-dependent airway (Fig 1, B) . C-F, Mouse DO11.10 T H 2 (Fig 1, C) , mouse T H 1 (Fig 1, D) , human CRTH2 1 (Fig 1, E inflammation marked by predominant eosinophil infiltration (Fig  5, B) . Ca v bAS administration decreased strongly the content of inflammatory cells in BAL fluid, including eosinophils and lymphocytes, compared with that seen in control mice treated or not with Ca v bS (Fig 5, B) . Consistently, histologic examination of lung tissues showed that Ca v bAS administration inhibited inflammatory infiltrates (Fig 5, C , and see Fig E3, A, in this article's Online Repository at www.jacionline.org). This protection was associated with defective T H 2 responses, as shown by the dramatic reduction in serum IgE concentration (Fig 5, D) and the reduced synthesis of IL-4, IL-5, and IL-13 by OVA-stimulated T cells from lung draining lymph node cells (Fig 5, E) . In accordance with the effects of Ca v bAS on airway inflammation, mice displayed reduced airway hyperresponsiveness (see Fig E4 in To investigate whether Ca v b expression in T H 2 cells was necessary and sufficient to control allergic asthma, we transferred OVA-specific TCR transgenic DO11.10 T H 2 cells transfected with Ca v bAS or Ca v bS in mice that were then challenged with intranasal OVA (Fig 6, A) . Ca v bAS-and Ca v bS-transfected T H 2 cells localized equally well in the lungs (Fig 6, B) . However, Ca v bAS-transfected T H 2 cells had reduced ability to promote the T H 2 response on airway challenge, as shown by the reduction in (Fig 3, B and C) and human CRTH2 1 cells (Fig 3, D and E) . The Ca v 1.2 cell amount over all the Z-stack sections is quantified in Fig 3, C and E. One representative experiment of 3 is shown. ****P < .001. lung inflammation (Fig 6, C and D , and see Fig E3, E) , the lower serum IgE concentration (Fig 6, E) , and the impaired T H 2 cytokine production after recall of antigen-specific draining lymph node T cells with OVA (Fig 6, F) . This was not associated with a shift toward a T H 1 response, as shown by the similar IFN-g production by OVA-stimulated draining lymph node cells from both groups (Fig 6, F) .
Gabapentin, an inhibitor of Ca v a2d, impairs T H 2 function and reduces allergic airway inflammation
Mouse T H 2 cells expressed mainly Ca v a2d2 (Fig 7, A) , as did human T H 2 cells. 9 Blotting and probing T H 2 cell or brain lysates with anti-a2d2 antibodies showed similar bands of around 140 kDa (Fig 7, B) . To investigate the role of a2d in Ca v 1-dependent T H 2 function, we used gabapentin, a ligand binding to Ca v a2d1 and a2d2 but not to the other a2d subunits. 32 Chronic in vitro treatment with this drug is known to inhibit Ca v currents. Accordingly, treatment of T H 2 cells with gabapentin for 72 hours decreased and delayed the TCR-driven calcium response (Fig 7, C) , as shown by quantification of the area under the curve and time of response, respectively (Fig 7, D and E) . This decrease in calcium signaling was associated with reduced T H 2 cytokine production (Fig 7, F) . However, gabapentin had no effect on calcium response and IFN-g production in T H 1 lymphocytes (see Fig E5 in this article' s Online Repository at www. jacionline.org).
Because gabapentin was reported to induce loss of the Ca v 2 complex at the cell membrane, 33, 34 we tested its effect on Ca v 1.2 protein expression in T H 2 cells. The amount of a2d2 protein was strongly reduced in gabapentin-treated T H 2 cells (Fig 7, G, (Fig 4, A) anti-Ca v b3 (Fig 4, B) , or anti-Ca v 1.2 a1 (Fig 4, C) mAbs.
Immunofluorescence was summed over all Z-sections. Results are expressed as the mean of 50 to 200 cells. Bars represent SEMs. One representative experiment of 3 is shown. D, Cytokine production was measured by ELISA. Results are expressed as the mean of 4 experiments, and bars represent SDs. *P < .05, **P < .01, and ****P < .001. (Fig 7, H , and see Fig E6) . Moreover, Bafilomycin A1, an inhibitor of the vacuolar H 1 ATPase that inhibited acidification and protein degradation in lysosomes, partially restored the amount of a2d2 in gabapentin-treated T H 2 lymphocytes (Fig 7, G, and see Fig E6) , demonstrating that gabapentin targeted a2d2 in lysosomes for its degradation.
We then examined the effect of gabapentin administration on the development of allergic airway inflammation (Fig 8, A) . Administration of gabapentin during OVA challenge partially reduced airway inflammation, as shown by the reduction in the number of inflammatory cells, including eosinophils in BAL fluid (Fig 8, B) and histologic examination of lung sections (Fig 8, C  and D) . Expression of T H 2 cytokines and mucins 5ac and 5b, which are the major components of mucus in the lungs, 35 was decreased in the lungs of gabapentin-treated mice (Fig 8, E) , supporting a beneficial effect of gabapentin on T H 2-mediated inflammation. Fig 5, B-E, are means of 5 mice and representative of 2 independent experiments. *P < .05, **P < .01, and ****P < .001.
DISCUSSION
transfected with Ca v bAS. In T H 2 cells, Ca v b prevents the degradation of Ca v 1.2 a1, which is consistent with findings showing that b1b or b2a might be required for Ca v 1.2 or Ca v 2.1 a1 protein expression. 28, 37 Surprisingly, transfection of ventricular myocytes with the same Ca v bAS we used in our study resulted in Ca v 1 a1 sequestration without increased cardiac Ca v 1.2 a1 degradation. 38 This apparent discrepancy could be related to differences in Ca v b subunit equipment and/or regulation in these cell types. Along this line, it has been shown that the absence of Ca v b4 resulted in decreased expression of Ca v 1.1 but not Ca v 1.2 a1 protein in CD4 1 T cells. 6 Two mechanisms have been proposed to explain how Ca v b can protect the a1 subunit from degradation. First, interaction of b2 with Ca v 1.2 a1 might limit degradation of the channel in lysosomes. 39 Second, interaction of b1 or b2 with Ca v 1.2 or Ca v 2.2 a1 prevents a1 being addressed to and degraded by the proteasome. 28, 37 This second mechanism is in agreement with our data in T H 2 cells. Indeed, we show that knocking down Ca v b diminished the total amount of endogenous Ca v 1.2 a1, which was partially restored on proteasome inhibition in T H 2 cells. Whether b subunits are also required for the export of a1 subunits to reach the cell surface is controversial. 23, 28, 40 Knocking down Ca v b resulted in lower expression of Ca v 1.2 a1 at the cell membrane, which was restored in part by the proteasome inhibitor, indicating that Ca v b was not absolutely required for the channel to exit from the ER or that the remaining Ca v b subunits were sufficient to promote trafficking of the channel at the cell membrane. The absence of Ca v b, even in the presence of proteasome inhibitor, did not allow restoration of cytokine production by T H 2 cells, which could be due to the incomplete restoration of Ca v 1.2 a1 and/or a role of Ca v b on function of the channel at the cell membrane.
Mouse T H 2 cells express predominantly both b1 and b3 subunits, as do human T H 2 cells. 9 It was reported previously that the b1 variant preferentially interacts with Ca v 1.1 a1, allowing interaction of Ca v 1 with ER-localized type 1 ryanodine receptors 41 and leading to calcium depletion in the ER. It would be interesting to investigate the respective roles of Ca v b1 and Ca v b3 in Ca v 1.2 function. Interestingly, Ca v b can interact with G proteins, scaffolding proteins, 42 and especially AHNAK, which might be required for plasma membrane localization of the channel, as described for Ca v 1.1 a1 channels in T cells. 43 We found predominantly a2d2 at the mRNA level in T H 2 cells. We also detected the protein by using Western blotting with the same apparent weight as in neurons and by means of immunofluorescence. Nerve injury can be responsible for chronic pain caused by a2d1 overexpression in injured sensory neurons. 44, 45 Gabapentin is beneficial because this drug, which binds to a2d1 and a2d1 but not the other a2d isoforms, 34 might decrease expression of Ca v 2 channels at the cell scored for inflammation. E, Serum IgE concentrations were measured at the time of death. F, Lung draining lymph node cells were recalled with OVA for determination of cytokine production. Each group comprised 5 mice. *P < .05, **P < .01, and ***P < .005.
membrane, 33, 34, 46 leading to a reduction in Ca v calcium currents. However, the authors did not report an effect of gabapentin on the total amount of a2d and Ca v a1 subunits. Unexpectedly, T H 2 cells treated with gabapentin show reduced total amounts of a2d2, which are restored by an inhibitor of the vacuolar H 1 ATPAse. This suggests that gabapentin favors a2d2 degradation in an acidic compartment, such as lysosomes. Along this line, gabapentin was shown to prevent recycling of a2d2 from Rab11-positive recycling endosomes to the plasma membrane. 47 We show here that gabapentin neither affects the total amount of Ca v 1.2 protein nor its localization at the plasma membrane in T H 2 cells. However, the calcium response was decreased on TCR activation, suggesting that a2d2 can contribute to the function of Ca v 1.2 a1, as described for a2d1. 48 Altogether, our results obtained with gabapentin and knockdown of Ca v b in the presence of MG132 indicate that the level of Ca v 1.2 a1 is not the only parameter limiting the calcium response and suggest that both auxiliary subunits are required in addition to Ca v 1.2 a1 for T H 2 functions.
Altogether, these data stress the role of auxiliary subunits (Ca v b and a2d) in Ca v 1.2 channel function in T H 2 cells and show that the auxiliary subunits of Ca v 1 channels represent potential new therapeutic targets in allergy. Consistently, Ca v bAS has a marked effect on T H 2 functions, airway inflammation, and hyperreactivity. CD4
1 T cells infiltrating the lungs express the Ca v 1.2 a1 channel, and this expression is diminished in mice during Ca v bAS treatment, suggesting that Ca v bAS acts in a similar way in vitro and in vivo. Chronic administration of gabapentin decreased T H 2 functions and inflammation. Because Ca v bAS and gabapentin act in different ways to decrease Ca 21 signaling and T H 2 function, it is tempting to propose a combination of drugs targeting Ca v b and Ca v a2d. In that respect, gabapentin is already used for the treatment of chronic cough, 49 a symptom that is currently found in asthmatic patients. Interestingly, peptides stapling the Ca v a1 domain interacting with Ca v b subunits and shown to inhibit Ca v functions have been recently described 50 and could be tested for their efficacy in allergic diseases.
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Clinical implications: The demonstration that auxiliary subunits are involved in calcium signaling through Ca v 1 channels and the function of mouse and human T H 2 lymphocytes supports their potential beneficial effect on allergic asthma.
METHODS
Oligonucleotide sequences
The sequences for Ca v bS (59-gaagtaggtcttggtggtgg-39) and Ca v bAS (59-accagccttccgatccaccagtcatt-3'; Eurogentec) were chosen from Bichet et al. E1 Ca v bAS has 92% complementarity to mouse or human b1 and b3 mRNA.
Model of acute allergic airway inflammation
BAL fluid was collected, and the content in inflammatory cells was determined, as previously described. E2 Lung tissue was fixed in 10% buffered formalin for 24 hours and then placed in 70% ethanol before embedding in paraffin. Sections (4 mm) were stained with hematoxylin and eosin. Histologic disease scores of 0 to 3 were attributed based on the severity of peribronchial, perivascular, and interstitial immune cell infiltration and thickening of peribronchial epithelium, resulting in a maximum score of 12. Lung draining lymph nodes were harvested, and 2 3 10 5 cells were stimulated with OVA (100 mg/mL) for 3 days. Cytokine concentrations were measured in supernatants by means of ELISA. In some experiments CD4
1 T cells were purified from the lungs, stained with anti-Ca v 1.2 antibodies, and analyzed by using confocal microscopy.
Airway hyperresponsiveness
Anesthetized and ventilated mice were connected through an endotracheal cannula to a whole-body plethysmograph for ventilation (Emka Technologies, Paris, France). After initiating mechanical ventilation, the mouse was paralyzed with an intraperitoneal injection of 0.1 mL of a 10 mg/mL solution of rocuronium bromide. The animal was ventilated at a respiratory rate of 150 breaths/min and a tidal volume of 10 mL/kg against a positive end-expiratory pressure of 3 cm of H 2 O. Then mice were exposed to increasing doses of methacholine aerosol generated through a nebulizer containing 0 to 20 mg/mL methacholine in PBS. Dynamic lung resistance was measured with iox software (Emka Technologies).
Cell culture
Cells were cultured in complete medium (RPMI 1640 supplemented with 10% FCS [Lonza, Allendale, NJ], 1% pyruvate, 1% nonessential amino acids, 2 mmol/L glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 50 mmol/L b-mercaptoethanol).
Single-cell calcium imaging
Cells were loaded with Fura-2 AM, as previously described, E2,E3 in culture medium containing 5% heat-inactivated FBS for 30 minutes at 378C. Cells were then washed, plated, and excited in 10-second intervals by using 340-and 380-nm excitation filters. Emission was recorded with 510/540-nm bandpass filters by using a CCD camera before and after stimulation with biotinylated anti-CD3 cross-linked with streptavidin-or anti-CD3/CD28-coated beads (1 bead per cell) for mouse or human T cells, respectively. Fluorescence ratio images at wavelengths of 340 and 380 nm were then calculated with Metafluor software. The curve represents the mean 1 SEM of fluorescence ratio of 40 to 60 cells. Each experiment was repeated 3 or 4 times. For each cell, we calculated the area under the curve between TCR stimulation and ionomycin application with the GraphPad Prism software. The time of response was defined as the delay for which the fluorescence ratio becomes superior to the mean basal value 1 1 SD.
Confocal microscopy
Cells were seeded onto glass slides coated with poly-L-lysine (Sigma-Aldrich, St Louis, Mo) and then fixated with 4% paraformaldehyde. Staining was performed with anti-CD2 rat IgG antibody (Abcam) or anti-a2d2 rabbit antibody (Alomone Labs) and revealed with the appropriate secondary antibodies (Molecular Probes, Eugene, Ore). Cells were then permeabilized with PBS containing 0.1% saponin and 0.5% BSA. 
